Compare
Blue Acquisition Corp/Cayman vs Thayer Ventures Acquisition Corp II vs Dynamix Corp III vs Oaktree Acquisition Corp. III Life Sciences
| Latest fiscal year | Blue Acquisition Corp/Cayman BACC | Thayer Ventures Acquisition Corp II TVAI | Dynamix Corp III DNMX | Oaktree Acquisition Corp. III Life Sciences OACC |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | n/a | n/a | n/a |
| Revenue growth (YoY) | n/a | n/a | n/a | n/a |
| Gross margin | n/a | n/a | n/a | n/a |
| Operating margin | n/a | n/a | n/a | n/a |
| Net margin | n/a | n/a | n/a | n/a |
| Net income | n/a | $3.88M | n/a | $7.29M |
| EPS (Diluted) | n/a | n/a | n/a | n/a |
| Operating cash flow | n/a | $617.1K | n/a | -$422.1K |
| Free cash flow | n/a | n/a | n/a | n/a |
| Cash & equivalents | $560.8K | $0 | $1.33M | $1.43M |
| Total assets | $206.33M | $206.82M | $203.94M | $203.11M |
| Total liabilities | $8.12M | $8.64M | $8.30M | $8.32M |
| Shareholders' equity | -$7.43M | -$8.18M | -$6.83M | -$6.77M |
| Return on year-end equity | n/a | n/a | n/a | n/a |
| Shares outstanding | n/a | n/a | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Blue Acquisition Corp/Cayman | Thayer Ventures Acquisition Corp II | Dynamix Corp III | Oaktree Acquisition Corp. III Life Sciences |
|---|---|---|---|---|
| Latest | n/a | n/a | n/a | n/a |
| 1 year earlier | n/a | n/a | n/a | n/a |
| 2 years earlier | n/a | n/a | n/a | n/a |
| 3 years earlier | n/a | n/a | n/a | n/a |
| 4 years earlier | n/a | n/a | n/a | n/a |